Filing Details

Accession Number:
0001209191-22-036008
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-10 17:07:04
Reporting Period:
2022-05-02
Accepted Time:
2022-06-10 17:07:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-02 20 $2.45 16,011 No 4 P Direct
Common Stock Acquisiton 2022-05-03 20 $2.42 16,031 No 4 P Direct
Common Stock Acquisiton 2022-05-04 20 $2.37 16,051 No 4 P Direct
Common Stock Acquisiton 2022-05-05 20 $2.35 16,071 No 4 P Direct
Common Stock Acquisiton 2022-05-06 20 $2.36 16,091 No 4 P Direct
Common Stock Acquisiton 2022-05-09 23 $2.63 16,114 No 4 P Direct
Common Stock Acquisiton 2022-05-10 23 $2.55 16,137 No 4 P Direct
Common Stock Acquisiton 2022-05-11 23 $2.37 16,160 No 4 P Direct
Common Stock Acquisiton 2022-05-12 23 $2.23 16,183 No 4 P Direct
Common Stock Acquisiton 2022-05-13 23 $2.32 16,206 No 4 P Direct
Common Stock Acquisiton 2022-05-16 23 $2.31 15,229 No 4 P Direct
Common Stock Acquisiton 2022-05-17 23 $2.35 16,252 No 4 P Direct
Common Stock Acquisiton 2022-05-18 23 $2.31 16,275 No 4 P Direct
Common Stock Acquisiton 2022-05-19 23 $2.29 16,298 No 4 P Direct
Common Stock Acquisiton 2022-05-20 23 $2.23 16,321 No 4 P Direct
Common Stock Acquisiton 2022-05-23 25 $2.17 16,346 No 4 P Direct
Common Stock Acquisiton 2022-05-24 25 $2.17 16,371 No 4 P Direct
Common Stock Acquisiton 2022-05-25 25 $2.15 16,396 No 4 P Direct
Common Stock Acquisiton 2022-05-26 25 $2.12 16,421 No 4 P Direct
Common Stock Acquisiton 2022-05-27 25 $2.13 16,446 No 4 P Direct
Common Stock Acquisiton 2022-05-31 25 $2.13 16,471 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.